Knight Therapeutics | GUD - Ebit



金融业
股票价格
CAD
资产
CAD 1.05B
现金及等价物
CAD 76.45M
销售成本
CAD 82.22M
流动资产
CAD 394.84M
流动负债
CAD 165.26M
债务
CAD 77.91M
EBIT
CAD 6.21M
EBITDA
CAD 24.45M
员工
698
EPS每股收益
CAD 0.13
股本和储备
CAD 767.27M
销售毛利
CAD 64.72M
债务利息支出
CAD 3.92M
利息收入
CAD 2.46M
贷款资金
CAD 57.78M
市值
CAD 977.31M
净收入
CAD -3.79M
营业费用
CAD 126.9M
营业利润
CAD 6.21M
普通股股本
CAD 99.68M
PE价格收益
257.34
税前利润
CAD -1.92M
销售收入
CAD 133.11M
销售和管理费用
CAD 35.45M
股票
CAD 95.4M
贸易债权人
CAD 125.76M
应收帐款人
CAD 183M


Ebit 更改 日
Acasti Pharma USD -3.7M 1.13M 2024-12
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.01M 175K 2026-03
Aurora Cannabis CAD 7.12M 42.91M 2026-03
Avita Medical AUD -10.39M 1.72M 2025-12
Canopy Growth CAD -145.65M 132.99M 2026-03
Cronos Group USD 7.6M 9.06M 2026-06
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Moderna USD -815M 573M 2026-06
Omeros USD -48.15M 7.25M 2023-09
Organigram Holdings CAD -9.79M 10.33M 2026-03
Organon & Co USD 291M 33M 2026-06
Revvity USD 126.14M 43.36M 2026-06
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
Tilray USD -20.01M 9.34M 2025-09
Viatris USD 73.7M 93.9M 2026-06
Xeris Pharmaceuticals USD 9.12M 7.65M 2026-03